Showing 171-180 of 360 results for "".
- Doctors in Great Britain Demand Crackdown on Rouge Beauty Operatorshttps://modernaesthetics.com/news/doctors-in-great-britain-demand-crackdown-on-rouge-beauty-operators/2473653/Doctors in Great Britain are standing behind a campaign focused on cracking down on unlicensed practitioners in the country’s aesthetic medicine industry, which is worth 3 billion Euros. A surge in the number of botched treatments by practitioners operating without a li
- Kenvue Introduces Patented Micro-Peptide Technology with Neutrogena Collagen Bank Launchhttps://modernaesthetics.com/news/kenvue-introduces-patented-micro-peptide-technology-with-neutrogena-collagen-bank-launch/2473651/Kenvue announced the launch of Neutrogena Collagen Bank featuring the company’s patented micro-peptide technology. The launch brings Neutrogena into the pre-aging catefory and is poised to meet the needs of Gen Z, a new generation of consumers. Neutrogena Collagen Bank aims
- Dermal Fillers Global Marketing Rising in Demandhttps://modernaesthetics.com/news/dermal-fillers-global-marketing-rising-in-demand/2473640/The dermal fillers global market size is expected to grow from almost $4 billion over the next seven years, reaching an estimated $7.58 billion by 2031. It’s anticipated to register a compound annual growth rate of 8.3% during the forecasted period, according to Premium Market Insights.&nbs
- First, Only US Neurotoxin for Simultaneous Treatment of Upper Facial Lines Gets FDA Approvalhttps://modernaesthetics.com/news/first-only-us-neurotoxin-for-simultaneous-treatment-of-upper-facial-lines-gets-fda-approval/2473638/Merz Aesthetics announced the US Food and Drug Administration approved XEOMIN (incobotulinumtoxinA) as the first and only neurotoxin for the simultaneous treatment of upper facial lines – forehead lines, frown lines, and crow’s feet. XEOMIN was first approved in 2011 f
- Botox Increases 20% in Italy, Non-surgical Procedures Becoming More Popularhttps://modernaesthetics.com/news/boxtox-increases-20-in-italy-non-surgical-procedures-becoming-more-popular/2473622/Botulinum toxin is becoming more and more popular in Italy. The International Society of Aesthetic Plastic Surgery’s 2023 ISAPS International Survey found there were 195,000 non-surgical aesthetics treatments with Botox, which is about 34,000 more than in 2022 and a 20% increase. I
- Anti-Aging Products Services, Devices Market Experiencing Significant Growthhttps://modernaesthetics.com/news/anti-aging-products-services-devices-market-experiencing-significant-growth/2473618/New research shows the Anti-Aging Products Services and Devices Market is experiencing significant growth. The surge is fueled by consumers desire to look and feel young. The industry’s current valuation is at $60.76 billion in 2024, according to a revised market report by F
- The Aesthetic Society Reports 10.2% Growth in Aesthetic Plastic Surgery from 2019 to 2023https://modernaesthetics.com/news/the-aesthetic-society-reports-102-growth-in-aesthetic-plastic-surgery-from-2019-to-2023/2473613/The Aesthetic Society’s annual Aesthetic Plastic Surgery National Databank report for 2023 projects a 10.2% growth in surgical procedures from 2019 to 2023. The data also revealed a 2.9% surge in total surgical procedures from 2022 to 2023. Researchers developed the statisti
- DailyMail.com Highlight’s Plastic Surgeon’s Warning on Lip Fillerhttps://modernaesthetics.com/news/dailymailcom-highlights-plastic-surgeons-warning-on-lip-filler/2473611/Britain's Daily Mail featured a top plastic surgeon warning people to be careful when getting lip filler after two friends revealed shocking results from injections. Deepak Dugar, MD, is a board-certified plastic surgeon and has treated celebrity patients, including Ti
- United Aesthetics Alliance appoints new chief executive officer, chief development officerhttps://modernaesthetics.com/news/united-aesthetics-alliance-appoints-new-chief-executive-officer-chief-development-officer/2473608/United Aesthetics Alliance (UAA) announced it has appointed Thomas Thill as chief executive officer and Benjamin Herbert as chief development officer to lead the company’s go-forward growth strategy. As an experienced healthcare leader, Thill joins UAA to build market-leadin
- Performance Beauty Company Submits Premarket Approval Application for Dermal Filler Productshttps://modernaesthetics.com/news/performance-beauty-company-submits-premarket-approval-application-for-dermal-filler-products/2473607/Evolus, Inc. submitted the final module of its permarket approval (PMA) application to the US Food and Drug Administration for dermal filler products. Evolysse Lift and Evolysse Smooth dermal fillers are for the nasolabial fold (NLF). Evolus expects the FDA’s